Authors: Bouchard, RH Demers, MF Simoneau, I Almeras, N Villeneuve, J Mottard, JP Cadrin, C Lemieux, I Despres, JP

Citation: Rh. Bouchard et al., Atypical antipsychotics and cardiovascular risk in schizophrenic patients, J CL PSYCH, 21(1), 2001, pp. 110-111

Authors: Simoneau, I Villeneuve, J Demers, MF Bouchard, RH

Citation: I. Simoneau et al., Schizophrenia and abuse of psychoactive substances: Problematic double diagnosis, CAN J PSY, 45(6), 2000, pp. 572-573

Authors: Bouchard, RH Merette, C Pourcher, E Demers, MF Villeneuve, J Roy-Gagnon, MH Gauthier, Y Cliche, D Labelle, A Filteau, MJ Roy, MA Maziade, M

Citation: Rh. Bouchard et al., Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia, J CL PSYCH, 20(3), 2000, pp. 295-304

Authors: Hamelin, BA Dorson, PG Pabis, D Still, D Bouchard, RH Pourcher, E Rail, J Turgeon, J Crismon, ML

Citation: Ba. Hamelin et al., CYP2D6 mutations and therapeutic outcome in schizophrenic patients, PHARMACOTHE, 19(9), 1999, pp. 1057-1063